Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review

MLA

Alicja Skrobucha, et al. “Anti-Inflammatory Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Artery Disease: A Comprehensive Review.” Frontiers in Cardiovascular Medicine, vol. 11, Dec. 2024. EBSCOhost, https://doi.org/10.3389/fcvm.2024.1446468.

APA

Alicja Skrobucha, Patryk Pindlowski, Natalia Krajewska, Marcin Grabowski, & Szymon Jonik. (2024). Anti-inflammatory effects of glucagon-like peptide-1 (GLP-1) in coronary artery disease: a comprehensive review. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1446468

Chicago

Alicja Skrobucha, Patryk Pindlowski, Natalia Krajewska, Marcin Grabowski, and Szymon Jonik. 2024. “Anti-Inflammatory Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Artery Disease: A Comprehensive Review.” Frontiers in Cardiovascular Medicine 11 (December). doi:10.3389/fcvm.2024.1446468.